These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 25955524)

  • 1. 4,5-cis unsaturated α-GalCer analogues distinctly lead to CD1d-mediated Th1-biased NKT cell responses.
    Cui Y; Li Z; Cheng Z; Xia C; Zhang Y
    Chem Res Toxicol; 2015 Jun; 28(6):1209-15. PubMed ID: 25955524
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 6'-derivatised alpha-GalCer analogues capable of inducing strong CD1d-mediated Th1-biased NKT cell responses in mice.
    Trappeniers M; Van Beneden K; Decruy T; Hillaert U; Linclau B; Elewaut D; Van Calenbergh S
    J Am Chem Soc; 2008 Dec; 130(49):16468-9. PubMed ID: 19554718
    [No Abstract]   [Full Text] [Related]  

  • 3. 3-fluoro- and 3,3-difluoro-3,4-dideoxy-KRN7000 analogues as new potent immunostimulator agents: total synthesis and biological evaluation in human invariant natural killer T cells and mice.
    Hunault J; Diswall M; Frison JC; Blot V; Rocher J; Marionneau-Lambot S; Oullier T; Douillard JY; Guillarme S; Saluzzo C; Dujardin G; Jacquemin D; Graton J; Le Questel JY; Evain M; Lebreton J; Dubreuil D; Le Pendu J; Pipelier M
    J Med Chem; 2012 Feb; 55(3):1227-41. PubMed ID: 22243602
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Introduction of aromatic group on 4'-OH of α-GalCer manipulated NKT cell cytokine production.
    Zhang W; Xia C; Nadas J; Chen W; Gu L; Wang PG
    Bioorg Med Chem; 2011 Apr; 19(8):2767-76. PubMed ID: 21439833
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Induction of Th1-biased cytokine production by alpha-carba-GalCer, a neoglycolipid ligand for NKT cells.
    Tashiro T; Sekine-Kondo E; Shigeura T; Nakagawa R; Inoue S; Omori-Miyake M; Chiba T; Hongo N; Fujii S; Shimizu K; Yoshiga Y; Sumida T; Mori K; Watarai H; Taniguchi M
    Int Immunol; 2010 Apr; 22(4):319-28. PubMed ID: 20181652
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Activation of human invariant natural killer T cells with a thioglycoside analogue of α-galactosylceramide.
    Hogan AE; O'Reilly V; Dunne MR; Dere RT; Zeng SG; O'Brien C; Amu S; Fallon PG; Exley MA; O'Farrelly C; Zhu X; Doherty DG
    Clin Immunol; 2011 Aug; 140(2):196-207. PubMed ID: 21493160
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis and biological activities of amino acids functionalized α-GalCer analogues.
    Ma W; Bi J; Zhao C; Zhang Z; Liu T; Zhang G
    Bioorg Med Chem; 2020 Jan; 28(1):115141. PubMed ID: 31786009
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis and evaluation of acyl-chain- and galactose-6''-modified analogues of α-GalCer for NKT cell activation.
    Hsieh MH; Hung JT; Liw YW; Lu YJ; Wong CH; Yu AL; Liang PH
    Chembiochem; 2012 Jul; 13(11):1689-97. PubMed ID: 22730199
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Amide analogues of CD1d agonists modulate iNKT-cell-mediated cytokine production.
    Wojno J; Jukes JP; Ghadbane H; Shepherd D; Besra GS; Cerundolo V; Cox LR
    ACS Chem Biol; 2012 May; 7(5):847-55. PubMed ID: 22324848
    [TBL] [Abstract][Full Text] [Related]  

  • 10. New CD1d agonists: synthesis and biological activity of 6″-triazole-substituted α-galactosyl ceramides.
    Jervis PJ; Graham LM; Foster EL; Cox LR; Porcelli SA; Besra GS
    Bioorg Med Chem Lett; 2012 Jul; 22(13):4348-52. PubMed ID: 22652050
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis of C6''-modified α-C-GalCer analogues as mouse and human iNKT cell agonists.
    Guillaume J; Seki T; Decruy T; Venken K; Elewaut D; Tsuji M; Van Calenbergh S
    Org Biomol Chem; 2017 Mar; 15(10):2217-2225. PubMed ID: 28221388
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Avidity of CD1d-ligand-receptor ternary complex contributes to T-helper 1 (Th1) polarization and anticancer efficacy.
    Wu TN; Lin KH; Chang YJ; Huang JR; Cheng JY; Yu AL; Wong CH
    Proc Natl Acad Sci U S A; 2011 Oct; 108(42):17275-80. PubMed ID: 21987790
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis and in vitro evaluation of alpha-GalCer epimers.
    Trappeniers M; Goormans S; Van Beneden K; Decruy T; Linclau B; Al-Shamkhani A; Elliott T; Ottensmeier C; Werner JM; Elewaut D; Van Calenbergh S
    ChemMedChem; 2008 Jul; 3(7):1061-70. PubMed ID: 18418814
    [TBL] [Abstract][Full Text] [Related]  

  • 14. NKT TCR recognition of CD1d-α-C-galactosylceramide.
    Patel O; Cameron G; Pellicci DG; Liu Z; Byun HS; Beddoe T; McCluskey J; Franck RW; Castaño AR; Harrak Y; Llebaria A; Bittman R; Porcelli SA; Godfrey DI; Rossjohn J
    J Immunol; 2011 Nov; 187(9):4705-13. PubMed ID: 21964029
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structure-activity relationship studies of Bz amide-containing α-GalCer derivatives as natural killer T cell modulators.
    Kishi J; Inuki S; Hirata N; Kashiwabara E; Yoshidome D; Ichihara O; Fujimoto Y
    Bioorg Med Chem Lett; 2019 Apr; 29(8):970-973. PubMed ID: 30824201
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of Th1/Th2 cytokine polarity induced by invariant NKT cells on the incidence of pregnancy loss in mice.
    Hoya M; Nagamatsu T; Fujii T; Schust DJ; Oda H; Akiba N; Iriyama T; Kawana K; Osuga Y; Fujii T
    Am J Reprod Immunol; 2018 Mar; 79(3):. PubMed ID: 29363849
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An alpha-galactosylceramide C20:2 N-acyl variant enhances anti-inflammatory and regulatory T cell-independent responses that prevent type 1 diabetes.
    Ly D; Tohn R; Rubin B; Blumenfeld H; Besra GS; Veerapen N; Porcelli SA; Delovitch TL
    Clin Exp Immunol; 2010 May; 160(2):185-98. PubMed ID: 20015094
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis of a 2"-deoxy-β-GalCer.
    Thakur MS; Khurana A; Kronenberg M; Howell AR
    Molecules; 2014 Jul; 19(7):10090-102. PubMed ID: 25014535
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Administration of anti-CD25 mAb leads to impaired α-galactosylceramide-mediated induction of IFN-γ production in a murine model.
    Rosalia RA; Štěpánek I; Polláková V; Šímová J; Bieblová J; Indrová M; Moravcová S; Přibylová H; Bontkes HJ; Bubeník J; Sparwasser T; Reiniš M
    Immunobiology; 2013 Jun; 218(6):851-9. PubMed ID: 23182710
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Species-specific activity of glycolipid ligands for invariant NKT cells.
    Dangerfield EM; Cheng JM; Knight DA; Weinkove R; Dunbar PR; Hermans IF; Timmer MS; Stocker BL
    Chembiochem; 2012 Jun; 13(9):1349-56. PubMed ID: 22639457
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.